Otros idiomas Eli Lilly and Company

Acciones

LLY

US5324571083

Farmacéuticos

Mercado cerrado - Nyse Otros sitios de cotización 22:00:02 13/02/2026			Variación 5 días	Varia. 1 de enero.
1.040,00 ^USD	+0,17 %		-0,45 %	-3,23 %

12:23	El fármaco contra el cáncer de pulmón de Eli Lilly alcanza su objetivo principal en un estudio de fase 3	MT
10:48	Lilly apunta a la India como centro mundial de exportación en medio del auge de las ventas de Mounjaro, según un ejecutivo	RE

Otros idiomas

12:23	Eli Lilly's Lung Cancer Drug Meets Main Goal in Phase 3 Study
11:07	USA-Les valeurs à suivre à Wall Street (actualisé)
10:48	Lilly targets India as global export hub amid booming Mounjaro sales, executive says
08:41	AlphaValue/Baader Europe Lifts Sandoz Price Target, Notes Biosimilar Momentum
16/02	Eli Lilly and Company Announces Positive Topline Results from the Phase 3 LIBRETTO-432 Clinical Trial of Retevmo
16/02	Lilly to participate in TD Cowen's 46th Annual Health Care Conference
16/02	USOPC Announces the Team USA Athlete Recovery Program in Partnership with Eli Lilly and Company
16/02	Drugmaker Sanofi to expand India GCC, increase workforce to over 4,500 employees
16/02	Lilly's Retevmo delivers event-free survival benefit as adjuvant therapy in early-stage RET fusion-positive lung cancer
16/02	Lilly's Retevmo (selpercatinib) delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer
16/02	Big tech stocks lose billions as AI spending fears hit valuations
13/02	Soros Fund Management cuts share stake in Alphabet, raises share stake in Apple, Uber
13/02	Borsa Usa verso calo settimanale, selloff tech offusca sollievo per inflazione
13/02	US could take action including fines against Hims after brief Wegovy copy launch
13/02	AlphaValue/Baader Europe Cuts Novo Nordisk Price Target, Forecasts Amid Outlook Downgrades, Competitive Pressures
12/02	Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision
12/02	Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision
12/02	Tranche Update on Eli Lilly and Company's Equity Buyback Plan announced on December 9, 2024.
12/02	West Pharma forecasts 2026 profit above estimates on strong demand for drug components
12/02	West Pharma forecasts 2026 profit above estimates on strong demand for drug components
12/02	Le Krach de l'Obésité : Fin de l'euphorie pour Novo Nordisk ? - La Finance Décomplexée
12/02	West Pharma forecasts 2026 profit above estimates on strong demand for drug components
11/02	Novo Nordisk plans to launch Wegovy vials
11/02	More than a third of patients on Wegovy pill are new to GLP-1 drugs, study finds
11/02	More than a third of patients on Wegovy pill are new to GLP-1 drugs, study finds

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Artículos de MarketScreener Estrategias MarketScreener Ideas de trading

Filtros

Acciones

Lilly reduce los precios para compradores en efectivo del medicamento para perder peso Zepbound

01 de diciembre 2025 a las 16:39